Revised forecast
Fiscal year ending November 2026 · Cumulative second-quarter (interim) consolidated periodPrevious forecast published 13 January 2026The bar length represents the relative magnitude of change, based on the item that changed the most in this document.
Net sales were broadly in line with the forecast. Against the backdrop of increased investment related to package substrates accompanying the rapid expansion of the generative AI market, profit contributions progressed in the Chemicals business, particularly in the surface treatment chemicals division, resulting in profit exceeding the forecast. From the third quarter onward, concerns include trends in raw material prices and supply restrictions arising from the situation in the Middle East, but the specific impact is still under review.
| Item | Details |
|---|---|
| Net Sales | ¥33,000 million → ¥34,566 million（+4.7%） |
| Operating profit | ¥1,600 million → ¥2,294 million（+43.4%） |
| Ordinary income | ¥1,550 million → ¥2,148 million（+38.6%） |
| Profit attributable to owners of the parent | ¥1,150 million → ¥1,417 million（+23.3%） |
| Net income per share | ¥28.49 → ¥35.10 |
| Fiscal Period Covered | Fiscal year ending November 2026 |
| Period Covered | Cumulative second-quarter (interim) consolidated period |
| Publication date of previous forecast | 13 January 2026 |
| Previous-period results | Net sales: ¥30,102 million; operating profit: ¥2,222 million; ordinary profit: ¥2,149 million; interim net income attributable to owners of the parent: ¥1,288 million; interim net income per share: ¥31.97 |
| Reason for the revision | Net sales were broadly in line with the forecast. Against the backdrop of increased investment related to package substrates accompanying the rapid expansion of the generative AI market, profit contributions progressed in the Chemicals business, particularly in the surface treatment chemicals division, resulting in profit exceeding the forecast. From the third quarter onward, concerns include trends in raw material prices and supply restrictions arising from the situation in the Middle East, but the specific impact is still under review. |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (2)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.While net sales were broadly in line with the forecast, investment related to package substrates became more active in the Chemicals business against the backdrop of the rapid expansion of the generative AI market. Profit contributions progressed, particularly in the surface treatment chemicals division, resulting in profit exceeding the forecast. The specific impact of raw material prices and supply restrictions arising from the situation in the Middle East is still under review.